Zynex, Inc. Stock

Equities

ZYXI

US98986M1036

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
11.45 USD -5.14% Intraday chart for Zynex, Inc. -5.68% +5.14%
Sales 2024 * 227M Sales 2025 * 290M Capitalization 385M
Net income 2024 * 17M Net income 2025 * 32M EV / Sales 2024 * 1.55 x
Net cash position 2024 * 33.11M Net cash position 2025 * 11.06M EV / Sales 2025 * 1.29 x
P/E ratio 2024 *
23.7 x
P/E ratio 2025 *
12.2 x
Employees 1,100
Yield 2024 *
-
Yield 2025 *
-
Free-Float 38.54%
More Fundamentals * Assessed data
Dynamic Chart
1 day-5.14%
1 week-5.68%
Current month-7.44%
1 month-9.49%
3 months+10.74%
6 months+36.96%
Current year+5.14%
More quotes
1 week
11.39
Extreme 11.39
12.34
1 month
11.39
Extreme 11.39
13.19
Current year
9.80
Extreme 9.8
13.77
1 year
6.88
Extreme 6.88
14.75
3 years
4.97
Extreme 4.97
17.25
5 years
4.69
Extreme 4.6909
27.02
10 years
0.06
Extreme 0.0552
27.02
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 95-12-31
Director of Finance/CFO 51 17-06-04
Chief Operating Officer 38 18-01-31
Members of the board TitleAgeSince
Director/Board Member 74 18-01-09
Chief Executive Officer 65 95-12-31
Director/Board Member 66 18-01-09
More insiders
Date Price Change Volume
24-04-18 11.45 -5.14% 177,420
24-04-17 12.07 -0.66% 100,409
24-04-16 12.15 +1.59% 115,501
24-04-15 11.96 +0.42% 91,201
24-04-12 11.91 -1.89% 157,974

Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT

More quotes
Zynex, Inc. develops, manufactures, markets and sells medical devices used for pain management and rehabilitation, as well as non-invasive fluid, sepsis and laser-based pulse oximetry monitoring systems for use in hospitals. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave and M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Distributed Complementary, which includes Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces and Bracing, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter and HemeOx tHb Oximeter.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
12.07 USD
Average target price
18.98 USD
Spread / Average Target
+57.25%
Consensus